Alterations in adrenergic receptor signaling in heart failure

被引：4

作者：

Lamba S. ^{[1
]}

Abraham W.T. ^{[1
,2
,3
]}

机构：

[1] Univ. of Cincinnati Coll. of Med., Cincinnati, OH

[2] Department of Medicine, Sect. Heart Failure Cardiac T., Univ. of Cincinnati Coll. of Med., Cincinnati, OH

[3] Sect. Heart Failure Cardiac T., Univ. of Cincinnati Coll. of Med., Cincinnati, OH 45267-0542

来源：

Heart Failure Reviews | 2000年 / 5卷 / 1期

关键词：

Adrenergic nervous system; Beta-adrenergic receptors; Heart failure; Norepinephrine;

D O I：

10.1023/A:1009885822076

中图分类号：

学科分类号：

摘要：

In the failing heart, several changes occur in cardiac adrenergic receptor-signal transduction pathways. The most striking of these changes occur in β-ARs, and of the changes in β-adrenergic receptors, β1-receptor down-regulation is the most prominent. Other changes include uncoupling of β2-adrenergic receptors and increased activity of the inhibitory G-protein, Gi. Most of these changes appear to be related to increased activity of the adrenergic nervous system, i.e. increased exposure to norepinephrine. Antagonists of the adrenergic nervous system improve left ventricular function and outcome in patients with heart failure. This fact supports the notion that activation of these neurohormonal systems exerts a net long-term detrimental effect on the natural history of chronic heart failure and that myocardial adrenergic desensitization phenomena are at least partially adaptive in the setting of left ventricular dysfunction.

引用

页码：7 / 16

页数：9

共 93 条

[31]

Bristow M.R., Ginsberg R., Fowler M., Et al., β1- And β2-adrenergic receptor subtype populations in normal and failing human ventricular myocardium, Circ Res, 59, pp. 297-309, (1986)

[32]

Brodde O.-E., Zerkowski H.R., Doetsch N., Motomura S., Khamssi M., Michel M.C., Myocardial beta-adrenoceptor changes in heart failure: Concomitant reduction in beta1- And beta2-adrenoceptor function related to the degree of heart failure in patients with mitral valve disease, J Am Coll Cardiol, 14, pp. 323-331, (1989)

[33]

Fowler M.B., Laser J.A., Hopkins G.L., Et al., Assessment of the beta-adrenergic receptor pathway in the intact failing human heart: Progressive downregulation and subsensitivity to agonist response, Circulation, 74, pp. 1290-1302, (1986)

[34]

Hausdorff W.P., Caron M.G., Lefkowitz R.J., Turning off the signal: Desensitization of β-adrenergic receptor function, FASEB J, 4, pp. 2881-2889, (1990)

[35]

Bouvier M., Collins S., O'Dowd B.F., Et al., Two distinct pathways for cAMP-mediated down-regulation of the β2-adrenergic receptor: Phosphorylation of the receptor and regulation of its mRNA level, J Biol Chem, 264, pp. 16786-16792, (1989)

[36]

Freedman N.J., Ligget S.B., De Drachman, Pei G., Caron M.G., Lefkowitz R.J., Phosphorylation and desensitization of the human β-adrenergic receptor, J Biol Chem, 270, pp. 17953-17961, (1995)

[37]

Ungerer M., Bohm M., Elce S., Erdmann E., Lohse M.J., Altered expression of β-adrenergic receptor kinase and β1-adrenergic receptors in the failing human heart, Circulation, 87, pp. 454-463, (1993)

[38]

Feldman A.M., Gates A.E., Veazey W.B., Et al., Increase of the Mr 40,000 pertussis toxin substrate (G protein) in the failing human heart, J Clin Invest, 82, pp. 189-197, (1988)

[39]

Bristow M.R., Minobe W., Rasmussen R., Et al., β-adrenergic neuroeffector abnormalities in the failing human heart are produced by local, rather than systemic mechanisms, J Clin Invest, 89, pp. 803-815, (1992)

[40]

Huang L., Tholanikunnel B.G., Vakalopoulou E., Et al., The M(r) 35,000 beta-adrenergic receptor mRNA-binding protein induced by beta agonists requires both an AUUUA pentamer and U-rich domains for RNA recognition, J Biol Chem, 268, pp. 25769-25775, (1993)

← 1 2 3 4 5 6 7 8 9 10 →